vs
Apellis Pharmaceuticals, Inc.（APLS）与SL GREEN REALTY CORP（SLG）财务数据对比。点击上方公司名可切换其他公司
SL GREEN REALTY CORP的季度营收约是Apellis Pharmaceuticals, Inc.的1.4倍（$276.5M vs $199.9M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -36.5%，领先7.0%），SL GREEN REALTY CORP同比增速更快（12.4% vs -5.9%），过去两年SL GREEN REALTY CORP的营收复合增速更高（21.3% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
SL Green Realty Corp是一家房地产投资信托企业，核心业务为投资纽约市的写字楼与商业中心，被誉为“纽约市最大的写字楼业主”。截至2024年12月31日，公司持有39处物业的权益，总面积达2529.7万平方英尺，资产主要分布在曼哈顿区域。
APLS vs SLG — 直观对比
营收规模更大
SLG
是对方的1.4倍
$199.9M
营收增速更快
SLG
高出18.4%
-5.9%
净利率更高
APLS
高出7.0%
-36.5%
两年增速更快
SLG
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $276.5M |
| 净利润 | $-59.0M | $-100.8M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 64.2% |
| 净利率 | -29.5% | -36.5% |
| 营收同比 | -5.9% | 12.4% |
| 净利润同比 | -62.2% | -870.0% |
| 每股收益（稀释后） | $-0.40 | $-1.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSSLG
| Q4 25 | $199.9M | $276.5M | ||
| Q3 25 | $458.6M | $244.8M | ||
| Q2 25 | $178.5M | $241.9M | ||
| Q1 25 | $166.8M | $239.8M | ||
| Q4 24 | $212.5M | $245.9M | ||
| Q3 24 | $196.8M | $229.7M | ||
| Q2 24 | $199.7M | $222.8M | ||
| Q1 24 | $172.3M | $187.9M |
净利润APLSSLG
| Q4 25 | $-59.0M | $-100.8M | ||
| Q3 25 | $215.7M | $28.6M | ||
| Q2 25 | $-42.2M | $-7.4M | ||
| Q1 25 | $-92.2M | $-17.3M | ||
| Q4 24 | $-36.4M | $19.1M | ||
| Q3 24 | $-57.4M | $-9.5M | ||
| Q2 24 | $-37.7M | $1.6M | ||
| Q1 24 | $-66.4M | $16.9M |
营业利润率APLSSLG
| Q4 25 | -25.6% | 64.2% | ||
| Q3 25 | 48.7% | 85.5% | ||
| Q2 25 | -18.6% | 53.4% | ||
| Q1 25 | -50.0% | 56.7% | ||
| Q4 24 | -12.3% | 59.8% | ||
| Q3 24 | -24.0% | 65.1% | ||
| Q2 24 | -14.7% | 79.2% | ||
| Q1 24 | -36.0% | — |
净利率APLSSLG
| Q4 25 | -29.5% | -36.5% | ||
| Q3 25 | 47.0% | 11.7% | ||
| Q2 25 | -23.6% | -3.0% | ||
| Q1 25 | -55.3% | -7.2% | ||
| Q4 24 | -17.1% | 7.8% | ||
| Q3 24 | -29.2% | -4.2% | ||
| Q2 24 | -18.9% | 0.7% | ||
| Q1 24 | -38.5% | 9.0% |
每股收益（稀释后）APLSSLG
| Q4 25 | $-0.40 | $-1.49 | ||
| Q3 25 | $1.67 | $0.34 | ||
| Q2 25 | $-0.33 | $-0.16 | ||
| Q1 25 | $-0.74 | $-0.30 | ||
| Q4 24 | $-0.30 | $0.13 | ||
| Q3 24 | $-0.46 | $-0.21 | ||
| Q2 24 | $-0.30 | $-0.04 | ||
| Q1 24 | $-0.54 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $155.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $3.7B |
| 总资产 | $1.1B | $11.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSSLG
| Q4 25 | $466.2M | $155.7M | ||
| Q3 25 | $479.2M | $187.0M | ||
| Q2 25 | $370.0M | $182.9M | ||
| Q1 25 | $358.4M | $180.1M | ||
| Q4 24 | $411.3M | $184.3M | ||
| Q3 24 | $396.9M | $188.2M | ||
| Q2 24 | $360.1M | $199.5M | ||
| Q1 24 | $325.9M | $196.0M |
总债务APLSSLG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSSLG
| Q4 25 | $370.1M | $3.7B | ||
| Q3 25 | $401.2M | $3.8B | ||
| Q2 25 | $156.3M | $3.8B | ||
| Q1 25 | $164.2M | $3.8B | ||
| Q4 24 | $228.5M | $4.0B | ||
| Q3 24 | $237.1M | $3.6B | ||
| Q2 24 | $264.3M | $3.7B | ||
| Q1 24 | $266.7M | $3.7B |
总资产APLSSLG
| Q4 25 | $1.1B | $11.1B | ||
| Q3 25 | $1.1B | $11.1B | ||
| Q2 25 | $821.4M | $11.3B | ||
| Q1 25 | $807.3M | $11.4B | ||
| Q4 24 | $885.1M | $10.5B | ||
| Q3 24 | $901.9M | $10.2B | ||
| Q2 24 | $904.5M | $9.5B | ||
| Q1 24 | $831.9M | $9.8B |
负债/权益比APLSSLG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $82.9M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSSLG
| Q4 25 | $-14.2M | $82.9M | ||
| Q3 25 | $108.5M | $-6.8M | ||
| Q2 25 | $4.4M | $54.5M | ||
| Q1 25 | $-53.4M | $6.7M | ||
| Q4 24 | $19.4M | $129.6M | ||
| Q3 24 | $34.1M | $16.7M | ||
| Q2 24 | $-8.3M | $79.4M | ||
| Q1 24 | $-133.0M | $-24.7M |
自由现金流APLSSLG
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSSLG
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSSLG
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
现金转化率APLSSLG
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | -0.24× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.77× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.33× | ||
| Q1 24 | — | -1.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
SLG
| Real Estate Segment | $223.1M | 81% |
| Other | $35.9M | 13% |
| Debt And Preferred Equity Segment | $17.4M | 6% |
